Liquid Melevodopa Versus Standard Levodopa in Patients With Parkinson Disease and Small Intestinal Bacterial Overgrowth-Reference-Cited by-同舟云学术

Liquid Melevodopa Versus Standard Levodopa in Patients With Parkinson Disease and Small Intestinal Bacterial Overgrowth

Published:2014-07 Issue:4 Volume:37 Page:91-95
ISSN:0362-5664
Container-title:Clinical Neuropharmacology
language:en
Short-container-title:

Author:

Fasano Alfonso,Bove Francesco,Gabrielli Maurizio,Ragazzoni Enzo,Fortuna Serena,Tortora Annalisa,Zocco Maria Assunta,Marconi Stefano,Gasbarrini Antonio,Bentivoglio Anna Rita

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Neurology (clinical),Pharmacology

Reference26 articles.

1. The history of dopamine and levodopa in the treatment of Parkinsons disease.;Fahn;Mov Disord,2008

2. The natural history of Parkinsons disease in the pre-levodopa and post-levodopa eras.;Hoehn;Neurol Clin,1992

3. Levodopa in the treatment of Parkinsons disease: current controversies.;Olanow;Mov Disord,2004

4. Motor fluctuations in Parkinsons disease: pathophysiology and treatment.;Colosimo;Eur J Neurol,1999

5. Gastric emptying in Parkinsons disease: patients with and without response fluctuations.;Djaldetti;Neurology,1996

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Variability in Levodopa Absorption and Clinical Implications for the Management of Parkinson’s Disease;Journal of Parkinson's Disease;2024-08-31

2. The gut-brain axis in Parkinson's disease;Revue Neurologique;2024-01

3. STN-DBS does not increase the risk of sialorrhea in patients with advanced Parkinson’s disease;npj Parkinson's Disease;2022-06-29

4. Inhaled levodopa for intermittent treatment of OFF episodes in patients with Parkinson’s disease;Expert Review of Clinical Pharmacology;2020-02-01

5. Old Drugs, New Delivery Systems in Parkinson’s Disease;Drugs & Aging;2019-06-03